Ariangela J Kozik, Fernando Holguin, Leopoldo N Segal, Talal A Chatila, Anne E Dixon, James E Gern, Catherine Lozupone, Nicholas Lukacs, Carey Lumeng, Philip L Molyneaux, Nichole Reisdorph, Ivan Vujkovic-Cvijin, Alkis Togias, Yvonne J Huang DOI: 10.1165/rcmb.2022-0216ST Free PMC article Abstract This report presents…
Ron Goldberg A machine learning system differentiated uncontrolled and controlled asthma in children with 81% accuracy in saliva samples and 86% accuracy in feces. Machine learning gastrointestinal microbiome analysis of…
Yenealem Solomon, Birhanemaskal Malkamu, Ayenew Berhan, Tahir Eyayu, Andargachew Almaw, Biruk Legese & Berhanu Woldu BMC Pulmonary Medicine volume 23, Article number: 96 (2023) Abstract Background Asthma is a diverse disease with various etiologic bases. Severe asthma can be associated with…
Saglani S, Yates L, Lloyd CM. Eur J Immunol. 2023 Mar 17:e2249919. doi: 10.1002/eji.202249919. Free Access Abstract Asthma is classically considered to be a disease of type 2 immune dysfunction,…
Research – Open Access Mohammad Talaei, Pauline M. Emmett, Raquel Granell, Hossein Tabatabaeian, Kate Northstone, Anna Bergström & Seif O. Shaheen Respiratory Research volume 24, Article number: 82 (2023) Abstract Background Longitudinal epidemiological data are scarce examining the relationship between dietary patterns…
ABSTRACT Background Severe uncontrolled asthma (SUA) is frequently treated with biologic therapy if a T2 phenotype is found. Bronchoscopy is not routinely recommended in these patients unless a specific indication…
Ron Goldberg Children and adolescents with asthma, particularly adolescent girls with asthma, frequently have comorbid dysfunctional breathing (DB), which is correlated with poorer asthma control and higher use of beta2…
P. Jane McDowell PhD MBBS, J. Busby PHD & Liam G. Heaney MD Abstract Purpose Advances in the management of severe, eosinophilic asthma have improved, but asthma exacerbations continue to occur. This review…
Theresa Capriotti; Natalie Dawn; Tabitha Ciocco Asthma is a common airway disease in the United States with 8.4% of adults or 21 million persons affected.1 Of this population, approximately 60% have…
A fifth of patients no longer needed oral steroids 2 years after starting biologic by Salynn Boyles SAN ANTONIO — Treatment with the interleukin-5 (IL-5) antagonist mepolizumab (Nucala) increased freedom from…